Speakers at a recent webinar laid out core priorities for federal agencies including the FDA and Department of Justice. Pandemic-related fraud, advertising to children, and corporate compliance programs are among the issues of note.
Data security, clinical trial practices and pandemic-related enforcement will remain priorities for federal agencies in the near future, speakers from the US Federal Trade Commission (FTC) and Department of Justice (DOJ) said at a 27 July webinar sponsored by the Food and Drug Law Institute.
For example, the FTC is still grappling with financial fraud tied to the COVID-19 pandemic, said Christine Lee DeLorme, an attorney in the FTC’s division of advertising practices
The World Health Organization is seeking input from stakeholders to create an official definition of the term ‘diagnostics.’ This initiative follows a 2023 resolution aimed at enhancing global diagnostics capacity; the definition, it is hoped, will help drive the creation of effective health policies. Comments will be accepted until 23 May.
HHS Secretary Robert F. Kennedy, Jr. is asking the public to help cut waste across the government’s health agencies. Kennedy announced a 60-day comment period allowing the public to take part in a broader federal initiative to reduce regulations and increase transparency.
The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.
